Autoimmune diseases comprise more than 80 different diseases that have in common a burden on health systems and are of unknown etiology. In general, in most countries, autoimmune diseases affect an ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

A new review by Dr. Ruyuan Wang and an international team of researchers explores the complex interactions between the innate and adaptive immune systems, shedding light on regulatory mechanisms in ...

Adaptive Biotechnologies plans to release its complete fourth quarter and full year 2025 financial results during its earnings call in February 2026. 1 Excludes Digital Biotechnologies, Inc. cash and ...